Mol Cell Biochem April 2021 PMID 33492609

Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis.

Zhengyao Song, Chen Jin, Zichen Bian, Chaozhao Liang

Mentions

4
Peak: 2 in Oct 2025
across 2 sources since Feb 2021

Extended reach

1,011
potential audience

Total likes

5

Video views

476

Mentions per month

Feb 2021 – Dec 2025

Where it's discussed

  • YouTube3 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

Discussions highlight the significance of the findings, with posts mentioning improvements in pelvic pain and mast cell reduction, using words like 'promising' and 'important,' which reflect genuine interest and recognition of potential impact. Readers navigate a balance between curiosity and cautious optimism, underscored by phrases that acknowledge the research's relevance without overstating immediate clinical applications.

AgreementModerate agreement

Most discussions express support or curiosity about the findings, indicating agreement that ESWT shows promise.

InterestModerate interest

Participants seem somewhat interested, posing questions or acknowledging the potential benefits without extensive controversy.

EngagementModerate engagement

The conversations include brief references to methodology and implications, showing moderate engagement.

ImpactModerate impact

The overall tone suggests recognition that this research could influence future treatments, though not yet transformative.

Abstract in brief

  • This study investigates how different energy levels of extracorporeal shock wave therapy (ESWT) impact the reduction of pelvic pain and mast cell activity in a rat model of chronic prostatitis/chronic pelvic pain syndrome (CPCPPS).
  • The research found that ESWT with an energy flux density of 0.02 mJ/mm² was most effective in alleviating pelvic pain and prostate damage, likely by decreasing both total and degranulated mast cells.
  • These findings suggest that choosing the appropriate ESWT energy level, specifically 0.02 mJ/mm², can improve treatment outcomes for managing pelvic pain associated with CPCPPS.]

Top posts

Most liked on X and Bluesky
Mastopedia
@mastopedia · X

Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis https://t.co/wD3EF3zydE

Feb 14, 2021 · 537 followers View post →

All mentions

Mastopedia
@mastopedia · X

Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis https://t.co/wD3EF3zydE

Feb 14, 2021 · 537 followers View post →